Cancer Atlas Achieves Critical Milestone

The Cancer and Organ Degradome Atlas (CODA) project, funded by Advanced Research Projects Agency for Health (ARPA-H), has been approved to continue into the next phase of research.  

In the initial phase, researchers proved it was possible to catalog the enzyme activity around tumors and healthy tissue. This earned the team approval to continue with the next phase, which uses the tool to understand the unique “signatures” for tumors from different kinds of cancer. 

CODA is led by Gabe A. Kwong, Robert A. Milton Professor in the Wallace H. Coulter Department of Biomedical Engineering, along with Georgia Tech researchers John Blazeck in the School of Chemical and Biomolecular Engineering and Peng Qiu in Coulter BME and colleagues at Columbia University and Mount Sinai.  

Read the full story from the College of Engineering.